Physician profile
Amer Mansoor
NPI 1568039675
$1,503.92
in general payments reported to CMS, 2019-2025
10 companies · $493 in 2025
The $493 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $611 · 2023: $369 · 2024: $31.90 · 2025: $493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $893.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $893.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $367.63 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Baudax Bio INC. | $227.51 | 2022 | |
| My01 INC. | $200.30 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Tela Bio, INC. | $146.74 | 2022 | |
| Heron Therapeutics, INC. | $144.95 | 2022-2023 | Zynrelef |
| Astrazeneca Pharmaceuticals LP | $143.70 | 2022-2024 | Andexxa |
| Csl Behring | $125.00 | 2025 | Kcentra |
| Polynovo North America LLC | $75.33 | 2023 | |
| Ethicon US, LLC | $55.10 | 2023 | Vicryl |
| Myriad Genetic Laboratories, INC. | $17.66 | 2024 | Myrisk |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amer Mansoor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.